Increased cellular expression of the caspase inhibitor FLIP in intrathecal lymphocytes from patients with multiple sclerosis

Journal of Neuroimmunology

Volumn 111, Issue 1-2, 2000, Pages 203-209

  Sharief, Mohammad K ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

Apoptosis; Caspace inhibition; FLIP; Multiple sclerosis

Indexed keywords

CASPASE INHIBITOR; FAS ANTIGEN; FLIP PROTEIN; MYELIN BASIC PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CEREBROSPINAL FLUID; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; MALE; MULTIPLE SCLEROSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ADOLESCENT; ADULT; ANTIGENS, CD95; CARRIER PROTEINS; CASPASES; CEREBROSPINAL FLUID; FEMALE; HUMAN; LYMPHOCYTES; MALE; MIDDLE AGE; MULTIPLE SCLEROSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; SUPPORT, NON-U.S. GOV'T;

EID: 0034333177     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(00)00310-6     Document Type: Article

References (37)

1. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
2. Serum sAPO-1/Fas levels in multiple sclerosis
3. TNF, apoptosis and autoimmunity: a common thread
4. Quantitation of proteoglycans as glycosaminoglycans in biological fluids using alcian blue dot blot analysis
5. Mechanisms of recovery from experimental autoimmune encephalomyelitis: T cell deletion and immune deviation in myelin basic protein T cell receptor transgenic mice
6. Soluble Fas (Apo-1) levels in cerebrospinal fluid of multiple sclerosis patients
7. Decreased Fas function in multiple sclerosis [abstract]
8. The role of the Bcl-2 family of apoptosis regulatory proteins in the immune system
9. Quantitating apoptosis by a nonradioactive DNA dot blot assay
10. Increased Fas antigen on T cells in multiple sclerosis
11. Primed T cells are more resistant to Fas-mediated activation-induced cell death than naive T cells
12. Inhibition of death receptor signals by cellular FLIP
13. FLIP prevents apoptosis induced by death receptors but not by perforin/granzyme B, chemotherapeutic drugs, and gamma irradiation
14. Expression of murine homologue of the inhibitor of apoptosis protein is related to cell proliferation
15. Impaired apoptosis in mitogen-stimulated lymphocytes of patients with multiple sclerosis
16. Immunology of multiple sclerosis and experimental allergic encephalomyelitis
17. The CD95 system and the death of a lymphocytes
18. Bcl-2 blocks glucocorticoid- but not Fas- or activation-induced apoptosis in a T cell hybridoma
19. Fas/Apo-1/CD95 in health and autoimmune disease: thymic and peripheral aspects
20. The role of programmed cell death as an emerging new concept for the pathogenesis of autoimmune diseases
21. Genetically determined failure of activation-induced apoptosis of autoreactive T cells as a cause of multiple sclerosis
22. FLICE-inhibitory protein expression during macrophage differentiation confers resistance to Fas-mediated apoptosis
23. ALPS: an autoimmune human lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis
24. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases
25. Bcl02 family members in the development and degenerative pathologies of the nervous system
26. The role of c-FLIP in modulation of CD95-induced apoptosis
27. Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis
28. Bcl-2 and Fas/Apo-1 regulate distinct pathways to lymphocyte apoptosis
29. Expression of K13/v-FLIP gene of human herpesvirus 8 and apoptosis in Kaposi's sarcoma spindle cells
30. Fas-mediated apoptosis in clinical remissions of relapsing experimental autoimmune encephalomyelitis
31. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptor
32. Inhibition of Fas death signals by FLIPs
33. Effect of bcl-2 proto-oncogene expression on cellular sensitivity to tumor necrosis factor-mediated cytotoxicity
34. Impaired apoptotic deletion of myelin basic protein-reactive T cells in patients with multiple sclerosis
35. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis
36. Increased serum levels of soluble CD95 (Apo1/Fas) in relapsing-remitting multiple sclerosis
37. CD95 expression and CD95-mediated apoptosis of T cells in multiple sclerosis. No difference from normal individuals and no relation to HLA-DR2